A group of the world\u0026#039;s richest nations vowed Sunday to collectively donate at least 1 billion coronavirus vaccine doses to developing nations over the next year, but a closer look reveals that the pledge includes just 613 million new doses—a paltry sum compared to the 11 billion doses that experts say will be needed to inoculate 70% of the global population.\r\n\r\n\u0022The G7 response to the scale of the challenge is just embarrassing.\u0022\r\n—Heidi Chow, Global Justice Now\r\n\r\nBloomberg\u0026#039;s Josh Wingrove and Alberto Nardelli reported that in order to reach the promised 1 billion-dose figure, G7 leaders \u0022included pledges made starting back in February.\u0022\r\n\r\n\u0022So far, the G7 countries have promised 613 million truly new doses—including some funded in part by previously announced aid,\u0022 Wingrove and\u0026nbsp;Nardelli noted. \u0022If doses already announced in recent weeks by G7 and E.U. nations are included, the tally grows to roughly 870 million doses.\u0022\r\n\r\n\u0022The 500 million doses pledged by the U.S. will be funded in part by $2 billion that Biden had initially promised for Covax, the World Health Organization-backed initiative aimed at facilitating equitable global distribution. Biden will claw that money back and buy doses directly, then work with Covax to distribute them,\u0022 the pair continued. \u0022The Canadian pledge includes 13 million directly donated doses as well as a previously announced C$440 million ($361.9 million) pledge to Covax. Counting that money, Canada framed its donation as up to 100 million doses total, though only the 13 million are new.\u0022\r\n\r\nAlready outraged by the inadequacy of the 1 billion-dose commitment—which, if fulfilled, would provide enough shots to protect just 11% of the world\u0026#039;s unvaccinated population—public health campaigners said the G7 countries\u0026#039; inflation of their pledge with older promises further underscores the failure of the closely watched summit in Cornwall, England over the weekend. The gathering took place as developing nations in Africa, South America, and Asia are experiencing deadly Covid-19 waves as they struggle to get their vaccination campaigns off the ground.\r\n\r\n\u0022Donations were never going to be enough, but the 1 billion doses promised by the G7 turns out to be just 613 million new doses and some through clawed back Covax financial donations,\u0022 said Heidi Chow, senior policy and campaigns manager with the U.K.-based advocacy group Global Justice Now. \u0022The G7 response to the scale of the challenge is just embarrassing.\u0022\r\n\r\nGlobal Justice Now\u0026#039;s director Nick Dearden echoed that message early Monday, tweeting that \u0022G7 leaders went to Cornwall and all the world got was 600 million truly new vaccine doses.\u0022\r\n\r\n\u0022A single factory could produce this number in a year if you waived patents,\u0022 Dearden added.\r\n\r\n\r\n\r\nThe G7 summit came amid ongoing negotiations over India and South Africa\u0026#039;s patent waiver proposal at the World Trade Organization. While the waiver is backed by more than 100 countries, the opposition of a small group of wealthy nations has prevented approval of the measure, which would temporarily lift intellectual property barriers that are stopping manufacturers around the world from producing generic vaccines.\r\n\r\nThe U.S. and France are the only two G7 nations that have endorsed the patent waiver.\r\n\r\n\u0022Dose-sharing is part of the solution if done immediately, but charity is not going to fix the colossal vaccine supply crisis,\u0022 said Anna Marriott, health policy manager at Oxfam International. \u0022In order to ramp up production, the G7 should break the pharmaceutical monopolies and insist that the vaccine science and know-how is shared with qualified manufacturers around the world.\u0022\r\n\r\n\u0022The lives of millions of people in developing countries should never be dependent on the good will of rich nations and profit-hungry pharmaceutical corporations,\u0022 Marriott added.